Report 37: “Despite Incomplete Safety Trials, the Food and Drug Administration (FDA) Grants Full Approval to Pfizer-BioNTech’s COMIRNATY® for Adolescents 12-15 Years of Age”

Without a completed safety study or expert committee review, the FDA issued a supplemental Biologics License Application (“sBLA”)…